Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar 24;20(6):2950-2955.
doi: 10.1016/j.radcr.2025.02.109. eCollection 2025 Jun.

Thoracic SMARCA4-deficient undifferentiated tumor

Affiliations
Case Reports

Thoracic SMARCA4-deficient undifferentiated tumor

Yukina Izumi et al. Radiol Case Rep. .

Abstract

Thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is characterized by an undifferentiated rhabdoid morphology and SMARCA4 deficiency pathologically. In the 2021 revision of the WHO classification, it was categorized as an epithelial tumor because of its shared genetic background with smoking-related lung cancer. We describe the case of a 44-year-old man with a rapidly enlarging mediastinal mass observed on chest radiography and CT. The tumor was resistant to radiation therapy, chemotherapy, and immune checkpoint inhibitors, and the patient's survival time was approximately 5 months. Familiarity with the clinical background and imaging findings of thoracic SMARCA4-UT is crucial for early diagnosis and treatment planning.

Keywords: CT; Heavy smokers; Mediastinal mass; SMARCA4-deficient undifferentiated tumor.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
(A and B) Noncontrast CT (2 weeks before admission), axial slices. A tumor measuring 5.0 × 5.0 cm was observed in the superior-to-anterior mediastinum.
Fig 2:
Fig. 2
Chest radiography at admission showed an enlarged shadow in the right upper mediastinum.
Fig 3
Fig. 3
(A-E) Dynamic CT axial and coronal images at admission. The tumor showed poor contrast enhancement, with gradual enhancement during the equilibrium phase. It had grown to 9.0 × 7.0 cm within 2 weeks, compressing the right brachiocephalic vein and superior vena cava (A, C, E). Enlarged metastatic lymph nodes were observed around the right pulmonary hilum and trachea (B, D).
Fig 4
Fig. 4
(A-D) HE staining revealed pleomorphic cells with prominent nucleoli and large nuclei proliferating in clusters, with extensive necrosis, apoptosis, and mitotic figures (A). Immunohistochemistry showed EMA positivity (B), weak AE1/AE3 positivity (C), and SMARCA4 negativity (D).
Fig 5
Fig. 5
(A-D) Head MRI shows T2WI (A), T1WI (B), and Gd-FS T1WI axial (C) and sagittal (D) images. A mass with low signal on T1WI, high signal on T2WI, and poor contrast enhancement is observed in the cortical to subcortical region of the right parietal lobe, indicating a brain metastasis with prominent internal necrosis.
Fig 6
Fig. 6
(A-D) Contrast-enhanced CT axial images on day 107 of hospitalization. The mediastinal tumor increased in size, measuring 11 × 8 cm (A). Metastases were observed in the right supraclavicular lymph nodes (B), multiple hepatic lesions (C), and upper abdominal lymph nodes (D).

References

    1. Le Loarer F., Watson S., Pierron G., de Montpreville VT., Ballet S., Firmin N., et al. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas. Nat Genet. 2015;47(10):1200–1205. doi: 10.1038/ng.3399. - DOI - PubMed
    1. Crombe A., Alberti N., Villard N., Pilleul F., Buy X., Le Loarer F., et al. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients. Eur Radiol. 2019;29(9):4730–4741. doi: 10.1007/s00330-019-06017-x. - DOI - PubMed
    1. Subasri A., Paul H., Marius I. Perspectives and issues in the assessment of SMARCA4 deficiency in the management of lung cancer patients. Cells. 2021;10(8):1920. doi: 10.3390/cells10081920. - DOI - PMC - PubMed
    1. Matsubara D., Kishaba Y., Ishikawa S., Sakatani T., Oguni A., Tamura T., et al. Lung cancer with loss of BRG1/BRM shows epithelial-mesenchymal transition phenotype and distinct histologic and genetic features. Cancer Sci. 2013;104(2):266–273. doi: 10.1111/cas.12065. - DOI - PMC - PubMed
    1. Zhang S., Xu W., Wu S., Chen M., Huang J., Sun Q., et al. Two cases of thoracic SMARCA4-deficient undifferentiated tumor: a case report. Clin Oncol 2022;7:1-4. Article 1964.

Publication types

LinkOut - more resources